Key Takeaways GLP-1 agonists are intended and approved to help with blood sugar regulation in type 2 diabetes patients, and in certain cases for clinical obesity, when no other methods have worked
When you eat, your body naturally releases GLP-1, which slows down digestion and tells your brain that youre full
These could indicate diabetic ketoacidosis or severe hyperglycaemia requiring immediate treatment
What Does AOD9604 Do in Research
PubMed abstract Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study Authors: Wagenknecht LE
So when they looked at age, baseline weight, type two diabetes, behavioral support, dietician support, that didn't have an impact, so accounting for all of that, the people in hormone replacement therapy still had better intended outcomes, which the intention was to lose weight